Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 208

1.

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Calderon MA, Demoly P, Casale T, Akdis CA, Bachert C, Bewick M, Bilò BM, Bohle B, Bonini S, Bush A, Caimmi DP, Canonica GW, Cardona V, Chiriac AM, Cox L, Custovic A, De Blay F, Devillier P, Didier A, Di Lorenzo G, Du Toit G, Durham SR, Eng P, Fiocchi A, Fox AT, van Wijk RG, Gomez RM, Haathela T, Halken S, Hellings PW, Jacobsen L, Just J, Tanno LK, Kleine-Tebbe J, Klimek L, Knol EF, Kuna P, Larenas-Linnemann DE, Linneberg A, Matricardi M, Malling HJ, Moesges R, Mullol J, Muraro A, Papadopoulos N, Passalacqua G, Pastorello E, Pfaar O, Price D, Del Rio PR, Ruëff R, Samolinski B, Scadding GK, Senti G, Shamji MH, Sheikh A, Sisul JC, Sole D, Sturm GJ, Tabar A, Van Ree R, Ventura MT, Vidal C, Varga EM, Worm M, Zuberbier T, Bousquet J.

Clin Transl Allergy. 2016 Nov 23;6:41. Review.

2.

Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française.

Zysman M, Chabot F, Devillier P, Housset B, Panzini CM, Roche N; Société de Pneumologie de Langue Française (SPLF)..

Rev Mal Respir. 2016 Nov 24. pii: S0761-8425(16)30198-X. doi: 10.1016/j.rmr.2016.10.004. [Epub ahead of print]

PMID:
27890625
3.

The impact of low-frequency, low-force cyclic stretching of human bronchi on airway responsiveness.

Le Guen M, Grassin-Delyle S, Naline E, Buenestado A, Brollo M, Longchampt E, Kleinmann P, Devillier P, Faisy C.

Respir Res. 2016 Nov 14;17(1):151.

4.
5.

In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures.

Devillier P, Bousquet J, Salvator H, Naline E, Grassin-Delyle S, de Beaumont O.

Clin Exp Allergy. 2016 Nov;46(11):1456-1464. doi: 10.1111/cea.12801.

PMID:
27562177
6.

300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.

Demoly P, Okamoto Y, Yang WH, Devillier P, Bergmann KC.

Expert Rev Clin Immunol. 2016 Nov;12(11):1141-1151.

PMID:
27632814
7.

Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department.

Gueho F, Beaune S, Devillier P, Urien S, Faisy C.

Medicine (Baltimore). 2016 Aug;95(32):e4553. doi: 10.1097/MD.0000000000004553.

8.

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PA, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Kaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N'Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GM, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.

Clin Transl Allergy. 2016 Jul 29;6:29. doi: 10.1186/s13601-016-0116-9. Review.

9.

Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber.

Roux M, Devillier P, Yang WH, Montagut A, Abiteboul K, Viatte A, Zeldin RK.

J Allergy Clin Immunol. 2016 Aug;138(2):451-458.e5. doi: 10.1016/j.jaci.2016.03.039.

PMID:
27289490
10.

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.

Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Spertini F, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Haahtela T, Zuberbier T; MASK study group*..

J Allergy Clin Immunol. 2016 Aug;138(2):367-374.e2. doi: 10.1016/j.jaci.2016.03.025.

11.

Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets.

Cox LS, Didier A, Demoly P, Wahn U, Pradalier A, Frew AJ, Devillier P.

J Allergy Clin Immunol. 2016 Jul;138(1):314-315.e4. doi: 10.1016/j.jaci.2016.01.039. No abstract available.

PMID:
27084407
12.

Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.

Morélot-Panzini C, Gilet H, Aguilaniu B, Devillier P, Didier A, Perez T, Pignier C, Arnould B, Similowski T.

Eur Respir J. 2016 Jun;47(6):1668-79. doi: 10.1183/13993003.01998-2015.

PMID:
27076585
13.

Comparison of outcome measures in allergic rhinitis in children, adolescents and adults.

Devillier P, Bousquet PJ, Grassin-Delyle S, Salvator H, Demoly P, Bousquet J, de Beaumont O.

Pediatr Allergy Immunol. 2016 Jun;27(4):375-81. doi: 10.1111/pai.12561.

PMID:
26949928
14.

Roflumilast n-oxide associated with PGE2 prevents the neutrophil elastase-induced production of chemokines by epithelial cells.

Victoni T, Gicquel T, Bodin A, Daude M, Tenor H, Valença S, Devillier P, Porto LC, Lagente V, Boichot E.

Int Immunopharmacol. 2016 Jan;30:1-8. doi: 10.1016/j.intimp.2015.11.019.

15.

Allergic rhinitis treatment with sublingual immunotherapy.

Devillier P.

J Pediatr. 2015 Nov;167(5):1169-70. doi: 10.1016/j.jpeds.2015.08.056. No abstract available.

PMID:
26603712
16.

Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire.

Gilet H, Pignier C, Aguilaniu B, Devillier P, Didier A, Perez T, Similowski T, Morélot-Panzini C.

Value Health. 2015 Nov;18(7):A712. doi: 10.1016/j.jval.2015.09.2683. No abstract available.

17.

Limited treatment adaptation despite poor asthma control in asthma patients treated with inhaled corticosteroids.

Roche N, Pribil C, Devillier P, Van Ganse E, Schück S, Doussaint J, Martin J, Nachbaur G, Boucot I.

J Asthma. 2016;53(1):76-85. doi: 10.3109/02770903.2015.1065421.

PMID:
26512745
18.

[Inhaled treatments: Choice of devices, systemic absorption of inhaled drugs and bitter taste receptors in the respiratory tract].

Benattia A, Cavaillon P, Gachelin E, Devillier P, Vecellio L, Williams G, Dubus JC.

Rev Mal Respir. 2015 Oct;32(8):791-9. doi: 10.1016/j.rmr.2014.06.032. Review. French.

PMID:
26480888
19.

Prevalence and reversibility of lung hyperinflation in adult asthmatics with poorly controlled disease or significant dyspnea.

Perez T, Chanez P, Dusser D, Devillier P.

Allergy. 2016 Jan;71(1):108-14. doi: 10.1111/all.12789.

PMID:
26466328
20.

House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.

Devillier P, Fadel R, de Beaumont O.

Allergy. 2016 Feb;71(2):249-57. doi: 10.1111/all.12791.

PMID:
26465232
Items per page

Supplemental Content

Loading ...
Support Center